DNA diagnostics is an offspring of the health segment that is a market that concerns specific technologies and methods belonging to the field of diagnostics of hereditary material. This extends from everyday tests that describe diseases genetically, the probability of certain diseases, and responses to particular drugs and treatments. DNA diagnostics in reality is a term that encompasses the vast range of tests that include but are not limited to PCR, NGS, and microarray. These tests are very important in that one can be able to predict the treatment policy basing on the result of the tests.

The diverticular disease market includes health care industry interest in diverticulosis and diverticulitis, diseases that are marked by small pouches, diverticula, in the colon wall that may become inflamed or infected. They are antibiotics, pain relaxing, and fibre supplements, operations, diagnostic measures, and preventive health measures. Some of the drivers for this market include; increase in proportion of geriatric population globally, increasing incidence of GI disorders, and technological improvement in diagnosis with better health management systems.